STENT GRAFT SYSTEM MARKET

INTRODUCTION

A Stent Graft System is a medical device used in the treatment of certain vascular conditions, particularly aortic aneurysms and aortic dissections.

It is made up of a graft, which is a tube made of synthetic fabric, and a stent, which is a mesh-like tube made of metal or fabric. A stent graft is used to strengthen and restore the body's weakened or damaged blood arteries.

Using an EVAR method to treat an aortic aneurysm is one example of a stent graft system in practise. The tear can be covered by a stent transplant, which allows blood to pass through and stops the aorta from suffering further harm.

RECENT DEVELOPMENT AND INNOVATION

Percutaneous transluminal implantation in coronary arteries or aortocoronary bypass grafts is permitted. BENTLEY INNOMED manufactures it, and CARDIVA distributes.This new generation of covered stents is extremely flexible due to the precise craftsmanship and unique design, while also ensuring an unparalleled low profile delivery (5F).

The Xcelerant Hydro Delivery System has a hydrophilic covering that helps the device go through restricted and tortuous arteries by decreasing friction with the arterial wall. The system will be used in conjunction with the AneuRx AAAdvantage Stent Graft, which was released.

The Xcelerant Hydro distribution System was demonstrated in laboratory tests to create 68 times less friction than the prior distribution system, which did not have the hydrophilic coating.

Endologix LLC, a leader in the treatment of vascular disease, announced today the first implant of its ALTO Abdominal Stent Graft in Canada, after Health Canada clearance. ALTO has also just received commercial approval in Argentina.

The first instance was conducted in Canada at Hôpital Saint-François-d'Assise in Quebec. Despite the existence of antagonistic neck architecture and tight access, ALTO was utilized for this patient within the recognised criteria for usage.

When a section of the abdominal aorta bulges into an aneurysm due to a weakening of the arterial wall, it can burst and cause life-threatening internal bleeding.

Patients with AAA can be treated surgically or with the less invasive Endovascular Aneurysm Repair (EVAR).

The ALTO Abdominal Stent Graft System is the next generation of polymer-based treatments for AAA patients, with a unique, patented sealing mechanism. ALTO contains an innovative conformable sealing ring that molds in-situ to the patient's individual aortic neck anatomy, unlike traditional EVAR devices.

Endologix offers a treatment portfolio focused on illnesses with clinically significant unmet needs. The products of the firm are intended to treat a wide range of vascular illness, from abdominal aortic aneurysms to lower limb peripheral vascular disease.

Excellent clinical outcomes are obtained by paying close attention to product design, manufacture, and training, all of which are supported by industry-leading clinical research.

Endologix's AAA devices are constructed on either a standard minimally invasive EVAR or an endovascular aneurysm sealing (EVAS) platform.

STENT GRAFT SYSTEM MARKET SIZE AND FORECAST

The Global Stent Graft System Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

STENT GRAFT SYSTEM MARKETTHIS REPORT WILL ANSWER FOLLOWING QUESTIONS

• How many  Stent Graft Systems   are manufactured per annum globally? Who are the sub-component suppliers in different regions?
• Cost breakup of a Global Stent Graft System   and key vendor selection criteria
• Where is the Stent Graft System  manufactured? What is the average margin per unit?
• Market share of Global Stent Graft System   market  manufacturers and their upcoming products
• Cost advantage for OEMs who manufacture Global Stent Graft System   in-house
• 5 key predictions for next 5 years in Global Stent Graft System   market
• Average B-2-B  Stent Graft System market price in all segments
• Latest trends in  Stent Graft System market, by every market segment
• The market size (both volume and value) of the  Stent Graft System   market in 2024-2030 and every year in between?
• Production breakup of  Stent Graft System   market, by suppliers and their OEM relationship